about
Autoimmunity and pregnancy.Thymectomy and azathioprine have no effect on the phenotype of CD4 T lymphocyte subsets in myasthenia gravisSpecific involvement of peripheral T lymphocytes against acetylcholine receptors in myasthenia gravisAcetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong ChineseImmunoadsorption plasmapheresis for severe generalised myasthenia gravis.Lymphocyte subpopulations and surface membrane immunoglobulins in myasthenia gravisSteroids induce acetylcholine receptors on cultured human muscle: implications for myasthenia gravis.Myasthenia gravis--current concepts.Tissue-specific antibodies in myasthenia gravis.Teaching monograph: pathology of skeletal muscle diseases.Antibody against the insulin receptor causes disappearance of insulin receptors in 3T3-L1 cells: a possible explanation of antibody-induced insulin resistance.Subunit structure of the acetylcholine receptor from Electrophorus electricus.Inhibitory effect of alpha-fetoprotein on the binding of myasthenia gravis antibody to acetylcholine receptor.Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors.Diaphragmatic myasthenia in mother and child.Controversies about the treatment of myasthenia gravis.Passively transferred myasthenia gravis: protection of mouse endplates by Fab fragments from human myasthenic IgG.Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts.Antibodies from patients with myasthenia gravis recognize determinants unique to extrajunctional acetylcholine receptorsDesensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibodyAcetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line.Effect of myasthenic patients' immunoglobulin on acetylcholine receptor turnover: selectivity of degradation processLaparoscopic Sleeve Gastrectomy in a Morbidly Obese Patient with Myasthenia Gravis: A Review of the Management.Mechanisms of acetylcholine receptor loss in myasthenia gravis.[Myasthenia gravis: treatment with thymectomy, corticoids and plasmapheresis]Monoclonal antibodies against defined determinants of acetylcholine receptor.Molecular events in synaptogenesis: nerve-muscle adhesion and postsynaptic differentiation.Anesthesia for pediatric neurological and neuromuscular diseases.The immunohistology of the thymus in myasthenia gravis.Myasthenia gravis: pathogenesis, diagnosis, and therapy.Naturally occurring antibodies to bovine and human retinal S antigen: a comparison between uveitis patients and healthy volunteers.Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation.Bispectral index-monitored anesthesia technique for transsternal thymectomy.Myasthenia gravis. A well-understood neuromuscular disorder.Voice spectrography in the evaluation of myasthenia gravis of the larynx.Increased potency of nondepolarizing relaxants after poliomyelitis.Adult-onset muscle weakness. How to identify the underlying cause.Autoimmune antireceptor diseases.The Use of Human Mesenchymal Stem Cells as Therapeutic Agents for the Treatment of Immune-Related Diseases: A Systematic Review
P2860
Q33458029-22E7155C-1D5F-4E04-A719-FF80DEF610BFQ33590421-C8C93998-A0B0-49D3-B847-F4980FC4F825Q33619130-E57FF973-B66E-4E81-85F5-30B04AA3907EQ33621733-E31F0BB6-4D75-45FD-B9AB-AAC0B956676FQ33622053-36D84020-D9FD-4F5B-8372-69E51584ED91Q33623758-FF79E568-F231-4549-9702-BDA34ED49027Q33755746-7237BA9C-74D9-4C05-BD74-6F7B59D4048CQ33850514-ED3D2DC6-1FE5-4B4D-B4BB-3D767594C6D7Q34192385-322B2FB0-A2E4-45D6-9C15-352038274EE9Q34860454-8FD78BDE-2B05-4591-A0CB-2964DDDD8503Q35884957-FFB0A11B-E464-4332-A18B-9F6D453E2B17Q36257870-0AE4DA54-1FCA-4263-A237-70698B71EAFEQ36318173-00752F76-9CFE-494A-9281-5272716DA280Q36394830-DDF7E6DE-2377-4BE9-A29C-E4985A92CA94Q36399303-89B0FAA3-60C4-4734-8563-F97B61B7F98BQ36706511-ECC63180-19B5-460A-9F00-B16B303331D3Q37000423-965F15CE-10DE-4B4D-8021-F1F68AADF131Q37001311-9076603C-2DED-4FD1-B2AD-AAEDD99D960DQ37024939-BF3FACF4-38B0-403C-A0A1-8C7A20FDBD8EQ37313102-A004B506-111A-4E4F-A1CE-61CF2E940787Q37315425-E6DA75E2-1526-4FBD-BC4A-5420CC65EB33Q37579285-2E7E7368-B139-4084-A14E-FC066C4404CEQ37590985-F64F1593-153B-4811-A5D4-9A81E045E885Q38570869-4C27CBBE-19BF-48BB-BF7A-30614FF6D0E1Q39237519-8581EF30-1156-48CE-9CD9-8CFD9A73C428Q39526305-AE1B48C6-F8E1-4CE4-AE11-01ED8827045AQ39572617-4BB69748-2F46-4753-8475-4D41FD3849C7Q39632767-275E97AF-323C-4C84-8FBD-9C1FB054DC2AQ39659416-695F6302-ABFF-401D-82F2-CB38D2B855BFQ41545385-2C1B2D19-CCE4-47D2-94AB-934A5A6CC37AQ41649054-CA7AD371-D4A2-4517-BA71-8EA3FB6914CCQ41950146-7E2C6729-61DA-4831-A600-197A8F96400CQ42927944-3683AECF-C861-4C2C-B4FE-DE37C5988FAFQ43284578-38EC4BC2-DD67-4ECC-B5BD-D64B2ED918E2Q44755831-DFBE4D12-8C6D-41D8-B410-5CD64DACD8B8Q44874738-A4AD9710-5646-4615-BBED-4B39E6255430Q51740084-333C15B5-C5AB-4631-B771-5C1DDABEBC4FQ54050694-14890B78-99BD-409D-98FF-72FAA6098659Q54538674-AAB9194E-D553-49DC-8C39-54CF4AA8BA5CQ57538743-6F315B4A-FED4-4B57-92EF-FB411AA3001E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 1978
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Myasthenia gravis (first of two parts).
@en
type
label
Myasthenia gravis (first of two parts).
@en
prefLabel
Myasthenia gravis (first of two parts).
@en
P1476
Myasthenia gravis (first of two parts).
@en
P2093
Drachman DB
P304
P356
10.1056/NEJM197801192980305
P407
P577
1978-01-01T00:00:00Z